Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04460664 · ClinicalTrials.gov registry record
Coagulation Changes Associated With COVID-19 Infection
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 15
- Enrollment target
NCT04460664: Completed study, sponsored by HemoSonics.
NCT04460664 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04460664 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.
Primary Outcome
Coagulation function assessed by the Quantra
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2022-01-26 |
What the finished NCT04460664 record still lists
NCT04460664 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT04460664 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04460664 about?
NCT04460664 is a clinical study titled "Coagulation Changes Associated With COVID-19 Infection". This study will study the potential utility of the Quantra QPlus System in patients inflicted with COVID-19 disease.
What is the current status of trial NCT04460664?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2020-08-14. Estimated completion is 2022-01-26.
What interventions are being tested in trial NCT04460664?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04460664?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI